Skip to main content
Top
Published in: Cancer Cell International 1/2006

Open Access 01-12-2006 | Primary research

Transfection of oral squamous cell carcinoma with human papillomavirus-16 induces proliferative and morphological changes in vitro

Authors: Karl Kingsley, Devin Johnson, Susan O'Malley

Published in: Cancer Cell International | Issue 1/2006

Login to get access

Abstract

Background

Human papillomavirus has been implicated in virtually all cervical cancers and is believed to be the primary etiological factor that transforms cervical epithelia. The presence of HPV in oral cancers suggests that HPV may play a similar role in transforming the oral epithelia. The prevalence of HPV in oral cancers is highly variable, however, presenting problematic issues regarding the etiology of oral cancers, which must be investigated more thoroughly. Past analyses of HPV in cancers of the oral cavity have largely been confined to retrospective studies of cancer patients. The purpose of this study was to examine the potential for HPV16 infection to alter the proliferative phenotype of oral squamous cell carcinoma in vitro.

Results

This study found that the oral squamous cell carcinoma cell line, CAL27, transfected with HPV16, exhibited significantly increased proliferation, compared with non-transfected CAL27. The increased proliferation was observed under low density conditions, even in the absence of serum. Moreover, these effects were specific to proliferation, adhesion, and morphology, while cell viability was not affected.

Conclusion

This study represents one of the first investigations of the effects of HPV16 infection on the proliferation, adhesion, and morphology of an oral squamous cell carcinoma cell line in vitro. The finding that HPV16 has the ability to measurably alter adhesion and proliferative potential is significant, indicating that HPV may have multiple influences on precancerous and cancerous lesions and should be explored as a risk factor and mediator of cancer phenotypes. These measurements and observations will be of benefit to researchers interested in elucidating the mechanisms of oral cancer transformation and the factors governing carcinogenesis and progression.
Appendix
Available only for authorised users
Literature
1.
go back to reference McCance DJ: Human papillomaviruses and cancer. Biochim Biophys Acta. 1986, 823: 195-205.PubMed McCance DJ: Human papillomaviruses and cancer. Biochim Biophys Acta. 1986, 823: 195-205.PubMed
2.
go back to reference McCance DJ, Kopan R, Fuchs E, Laimins LA: Human papillomavirus type 16 alters human epithelial cell differentiation in vitro. Proc Natl Acad Sci USA. 1988, 85: 7169-7173.PubMedCentralCrossRefPubMed McCance DJ, Kopan R, Fuchs E, Laimins LA: Human papillomavirus type 16 alters human epithelial cell differentiation in vitro. Proc Natl Acad Sci USA. 1988, 85: 7169-7173.PubMedCentralCrossRefPubMed
3.
go back to reference Zhou W, Tyring SK, Brysk M, Chan T: Immortalization of differentiated human keratinocytes by human papillomavirus (HPV) 16 DNA. Journal of Dermatological Science. 1996, 13: 140-152. 10.1016/S0923-1811(96)00520-8.CrossRefPubMed Zhou W, Tyring SK, Brysk M, Chan T: Immortalization of differentiated human keratinocytes by human papillomavirus (HPV) 16 DNA. Journal of Dermatological Science. 1996, 13: 140-152. 10.1016/S0923-1811(96)00520-8.CrossRefPubMed
4.
go back to reference Walboomers JMM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJF, Peto J, Meijer CJLM, Munoz N: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. Journal of Pathology. 1999, 189: 12-19. 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F.CrossRefPubMed Walboomers JMM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJF, Peto J, Meijer CJLM, Munoz N: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. Journal of Pathology. 1999, 189: 12-19. 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F.CrossRefPubMed
5.
go back to reference Ha PK, Califano JA: The role of human papillomavirus in oral carcinogenesis. Crit Rev Oral Biol Med. 2004, 15: 188-196.CrossRefPubMed Ha PK, Califano JA: The role of human papillomavirus in oral carcinogenesis. Crit Rev Oral Biol Med. 2004, 15: 188-196.CrossRefPubMed
6.
go back to reference Paz IB, Cook N, Odom-Maryon T, Xie Y, Wilcyznski SP: Human papillomavirus (HPV) in head and neck cancer. An association of HPV 16 with squamous cell carcinoma of Waldeyer's tonsillar ring. Cancer. 1997, 79: 595-604. 10.1002/(SICI)1097-0142(19970201)79:3<595::AID-CNCR24>3.0.CO;2-Y.CrossRefPubMed Paz IB, Cook N, Odom-Maryon T, Xie Y, Wilcyznski SP: Human papillomavirus (HPV) in head and neck cancer. An association of HPV 16 with squamous cell carcinoma of Waldeyer's tonsillar ring. Cancer. 1997, 79: 595-604. 10.1002/(SICI)1097-0142(19970201)79:3<595::AID-CNCR24>3.0.CO;2-Y.CrossRefPubMed
7.
go back to reference Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, Zahurak ML, Daniel RW, Viglione M, Symer DE, Shah KV, Sidransky D: Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000, 92: 675-677. 10.1093/jnci/92.9.709.CrossRef Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, Zahurak ML, Daniel RW, Viglione M, Symer DE, Shah KV, Sidransky D: Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000, 92: 675-677. 10.1093/jnci/92.9.709.CrossRef
8.
go back to reference Ha PK, Pai SI, Westra WH, Gillison ML, Tong BC, Sidransky D, Califano JA: Real-time quantitative PCR demonstrates low prevalence of human papillomavirus type 16 in premalignant and malignant lesions of the oral cavity. Clinical Cancer Research. 2002, 8: 1203-1209.PubMed Ha PK, Pai SI, Westra WH, Gillison ML, Tong BC, Sidransky D, Califano JA: Real-time quantitative PCR demonstrates low prevalence of human papillomavirus type 16 in premalignant and malignant lesions of the oral cavity. Clinical Cancer Research. 2002, 8: 1203-1209.PubMed
9.
go back to reference Dai M, Clifford GM, le Calvez F, Castellsague X, Snijders PJF, Pawlita M, Herrero R, Hainaut P, Franceschi S: Human papillomavirus type 16 and TP53 mutation in oral cancer: matched analysis of the IARC multicenter study. Cancer Research. 2004, 64: 468-471. 10.1158/0008-5472.CAN-03-3284.CrossRefPubMed Dai M, Clifford GM, le Calvez F, Castellsague X, Snijders PJF, Pawlita M, Herrero R, Hainaut P, Franceschi S: Human papillomavirus type 16 and TP53 mutation in oral cancer: matched analysis of the IARC multicenter study. Cancer Research. 2004, 64: 468-471. 10.1158/0008-5472.CAN-03-3284.CrossRefPubMed
10.
go back to reference Syrjanen S: Human papillomavirus (HPV) in head and neck cancer. J Clin Virol. 2005, 32: S59-66. 10.1016/j.jcv.2004.11.017.CrossRefPubMed Syrjanen S: Human papillomavirus (HPV) in head and neck cancer. J Clin Virol. 2005, 32: S59-66. 10.1016/j.jcv.2004.11.017.CrossRefPubMed
11.
go back to reference Werness BA, Levine AJ, Howley PM: Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science. 1990, 248: 76-79.CrossRefPubMed Werness BA, Levine AJ, Howley PM: Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science. 1990, 248: 76-79.CrossRefPubMed
12.
go back to reference Hollstein M, Sidransky D, Vogelstein B, Harris CC: p53 mutations in human cancers. Science. 1991, 253: 49-53.CrossRefPubMed Hollstein M, Sidransky D, Vogelstein B, Harris CC: p53 mutations in human cancers. Science. 1991, 253: 49-53.CrossRefPubMed
13.
go back to reference Piboonniyom S, Duensing S, Swilling NW, Hasskarl J, Hinds PW, Munger K: Abrogation of the retinoblastoma tumor suppressor checkpoint during keratinocyte immortalization is not sufficient for induction of centrosome-mediated genomic instability. Cancer Research. 2003, 63: 476-483.PubMed Piboonniyom S, Duensing S, Swilling NW, Hasskarl J, Hinds PW, Munger K: Abrogation of the retinoblastoma tumor suppressor checkpoint during keratinocyte immortalization is not sufficient for induction of centrosome-mediated genomic instability. Cancer Research. 2003, 63: 476-483.PubMed
14.
go back to reference Eike A, Buchwald C, Rolighed J, Lindelberg H: Human papillomavirus (HPV) is rarely present in normal oral and nasal mucosa. Clin Otolaryngol. 1995, 20: 171-173.CrossRefPubMed Eike A, Buchwald C, Rolighed J, Lindelberg H: Human papillomavirus (HPV) is rarely present in normal oral and nasal mucosa. Clin Otolaryngol. 1995, 20: 171-173.CrossRefPubMed
15.
go back to reference Bouda M, Gorgoulis VG, Kastrinakis NG, Giannoudis A, Tsoli E, Danassi-Afentaki D, Foukas P, Kyroudi A, Laskaris G, Herrington CS, Kittas C: "High risk" HPV types are frequently detected in potentially malignant and malignant oral lesions, but not in normal oral mucosa. Mod Pathol. 2000, 13: 644-653. 10.1038/modpathol.3880113.CrossRefPubMed Bouda M, Gorgoulis VG, Kastrinakis NG, Giannoudis A, Tsoli E, Danassi-Afentaki D, Foukas P, Kyroudi A, Laskaris G, Herrington CS, Kittas C: "High risk" HPV types are frequently detected in potentially malignant and malignant oral lesions, but not in normal oral mucosa. Mod Pathol. 2000, 13: 644-653. 10.1038/modpathol.3880113.CrossRefPubMed
16.
go back to reference Smola-Hess S, Pahne J, Mauch C, Zigrino P, Smola H, Pfister HJ: Expression of membrane type 1 matrix metalloproteinase in papillomavirus-positive cells: role of the human papillomavirus (HPV) 16 and HPV8 E7 gene products. Journal of General Virology. 2005, 86: 1291-1296. 10.1099/vir.0.80551-0.CrossRefPubMed Smola-Hess S, Pahne J, Mauch C, Zigrino P, Smola H, Pfister HJ: Expression of membrane type 1 matrix metalloproteinase in papillomavirus-positive cells: role of the human papillomavirus (HPV) 16 and HPV8 E7 gene products. Journal of General Virology. 2005, 86: 1291-1296. 10.1099/vir.0.80551-0.CrossRefPubMed
17.
go back to reference van Houten VM, Snijders PJ, van den Brekel MW, Kummer JA, Meijer CJ, van Leeuwen B, Denkers F, Smeele LE, Snow GB, Brakenhoff RH: Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas. Int J Cancer. 2001, 93: 232-235. 10.1002/ijc.1313.CrossRefPubMed van Houten VM, Snijders PJ, van den Brekel MW, Kummer JA, Meijer CJ, van Leeuwen B, Denkers F, Smeele LE, Snow GB, Brakenhoff RH: Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas. Int J Cancer. 2001, 93: 232-235. 10.1002/ijc.1313.CrossRefPubMed
18.
go back to reference Sugerman PB, Shillitoe EJ: The high risk human papillomaviruses and oral cancer: evidence for and against a causal relationship. Oral Dis. 1997, 3: 130-147.CrossRefPubMed Sugerman PB, Shillitoe EJ: The high risk human papillomaviruses and oral cancer: evidence for and against a causal relationship. Oral Dis. 1997, 3: 130-147.CrossRefPubMed
19.
go back to reference Hodivala KJ, Pei XF, Liu QY, Jones PH, Rytina ER, Gilbert C, Singer A, Watt FM: Integrin expression and function in HPV 16-immortalised human keratinocytes in the presence or absence of v-Ha-ras. Comparison with cervical intraepithelial neoplasia. Oncogene. 1994, 9: 943-948.PubMed Hodivala KJ, Pei XF, Liu QY, Jones PH, Rytina ER, Gilbert C, Singer A, Watt FM: Integrin expression and function in HPV 16-immortalised human keratinocytes in the presence or absence of v-Ha-ras. Comparison with cervical intraepithelial neoplasia. Oncogene. 1994, 9: 943-948.PubMed
20.
go back to reference McCormack SJ, Brazinski SE, Moore JL, Werness BA, Goldstein DJ: Activation of the focal adhesion kinase signal transduction pathway in cervical carcinoma cell lines and human genital epithelial cells immortalized with human papillomavirus type 18. Oncogene. 1997, 15: 265-274. 10.1038/sj.onc.1201186.CrossRefPubMed McCormack SJ, Brazinski SE, Moore JL, Werness BA, Goldstein DJ: Activation of the focal adhesion kinase signal transduction pathway in cervical carcinoma cell lines and human genital epithelial cells immortalized with human papillomavirus type 18. Oncogene. 1997, 15: 265-274. 10.1038/sj.onc.1201186.CrossRefPubMed
21.
go back to reference Masur SK, Idris A, Michelson K, Antoli S, Zhu LX, Weissberg J: Integrin-dependent tyrosine phosphorylation in corneal fibroblasts. Invest Ophthalmol Vis Sci. 1995, 36: 1837-1846.PubMed Masur SK, Idris A, Michelson K, Antoli S, Zhu LX, Weissberg J: Integrin-dependent tyrosine phosphorylation in corneal fibroblasts. Invest Ophthalmol Vis Sci. 1995, 36: 1837-1846.PubMed
22.
go back to reference Richardson A, Parsons T: A mechanism for regulation of the adhesion-associated protein tyrosine kinase pp125FAK. Nature. 1996, 380: 538-540. 10.1038/380538a0.CrossRefPubMed Richardson A, Parsons T: A mechanism for regulation of the adhesion-associated protein tyrosine kinase pp125FAK. Nature. 1996, 380: 538-540. 10.1038/380538a0.CrossRefPubMed
23.
go back to reference Fregonesi PAG, Teresa DB, Duarte RA, Neto CB, de Oliveira MRB, Soares CP: p16INK4A immunohistochemical overexpression in premalignant and malignant oral lesions infected with human papillomavirus. J Histochem Cytochem. 2003, 51: 1291-1297.CrossRefPubMed Fregonesi PAG, Teresa DB, Duarte RA, Neto CB, de Oliveira MRB, Soares CP: p16INK4A immunohistochemical overexpression in premalignant and malignant oral lesions infected with human papillomavirus. J Histochem Cytochem. 2003, 51: 1291-1297.CrossRefPubMed
24.
go back to reference Felsher DW, Zetterberg A, Zhu J, Tlsty T, Bishop JM: Overexpression of MYC causes p53-dependent G2 arrest of normal fibroblasts. Proc Natl Acad Sci USA. 2000, 97: 10544-10548. 10.1073/pnas.190327097.PubMedCentralCrossRefPubMed Felsher DW, Zetterberg A, Zhu J, Tlsty T, Bishop JM: Overexpression of MYC causes p53-dependent G2 arrest of normal fibroblasts. Proc Natl Acad Sci USA. 2000, 97: 10544-10548. 10.1073/pnas.190327097.PubMedCentralCrossRefPubMed
25.
go back to reference Kingsley K, Huff JL, Rust WL, Carroll K, Martinez AM, Fitchmun M, Plopper GE: ERK1/2 mediates PDGF-BB stimulated vascular smooth muscle cell proliferation and migration on laminin-5. Biochem Biophys Res Commun. 2002, 293: 1000-1006. 10.1016/S0006-291X(02)00331-5.CrossRefPubMed Kingsley K, Huff JL, Rust WL, Carroll K, Martinez AM, Fitchmun M, Plopper GE: ERK1/2 mediates PDGF-BB stimulated vascular smooth muscle cell proliferation and migration on laminin-5. Biochem Biophys Res Commun. 2002, 293: 1000-1006. 10.1016/S0006-291X(02)00331-5.CrossRefPubMed
26.
go back to reference Plopper GE, McNamee HP, Bojanowski K, Ingber DE: Convergence of integrin and growth factor receptor signaling pathways within the focal adhesion complex. Molecular Biology of the Cell. 1995, 6: 1349-1365.PubMedCentralCrossRefPubMed Plopper GE, McNamee HP, Bojanowski K, Ingber DE: Convergence of integrin and growth factor receptor signaling pathways within the focal adhesion complex. Molecular Biology of the Cell. 1995, 6: 1349-1365.PubMedCentralCrossRefPubMed
27.
go back to reference Wagner JE, Huff JL, Rust WL, Kingsley K, Plopper GE: Perillyl alcohol inhibits breast cell migration without affecting cell adhesion. Journal of Biomedicine and Biotechnology. 2002, 2: 136-140. 10.1155/S1110724302207020.PubMedCentralCrossRefPubMed Wagner JE, Huff JL, Rust WL, Kingsley K, Plopper GE: Perillyl alcohol inhibits breast cell migration without affecting cell adhesion. Journal of Biomedicine and Biotechnology. 2002, 2: 136-140. 10.1155/S1110724302207020.PubMedCentralCrossRefPubMed
28.
go back to reference Hays WL: Inferences about population means. Statistics. 1994, International Thomson Publishing, 311-342. 5 Hays WL: Inferences about population means. Statistics. 1994, International Thomson Publishing, 311-342. 5
Metadata
Title
Transfection of oral squamous cell carcinoma with human papillomavirus-16 induces proliferative and morphological changes in vitro
Authors
Karl Kingsley
Devin Johnson
Susan O'Malley
Publication date
01-12-2006
Publisher
BioMed Central
Published in
Cancer Cell International / Issue 1/2006
Electronic ISSN: 1475-2867
DOI
https://doi.org/10.1186/1475-2867-6-14

Other articles of this Issue 1/2006

Cancer Cell International 1/2006 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine